COVID‐19 has affected over a billion people around the world, with over 2 million losing their lives (Worldometer). About 10% of patients infected with COVID‐19 develop a serious illness, including respiratory failure, that require advanced life‐supporting measures. Mortality among this subgroup exceeds 60%. We present a case of an otherwise healthy 34‐year‐old male who developed end‐stage pulmonary fibrosis following COVID‐19 infection. He achieved haemodynamic stability with mechanical ventilation and extracorporeal membrane oxygenation (ECMO) but did not show any sign of weaning off ECMO; however, he successfully underwent bilateral lung transplantation. This case study describes the comprehensive care of a patient with complicated COVID‐19‐related adult respiratory distress syndrome using clinical judgement and advanced modalities such as extracorporeal membrane oxygenation and lung transplantation (Ltx). Final outcome is favourable, asserting better defined indications for Ltx in severe COVID‐19 cases.